Vanguard Group Inc Synthetic Biologics, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.99 - $2.4 $5.24 Million - $12.7 Million	-5,296,501 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.3 - $4.3 $110,634 - $206,838	48,102 Added 0.92%	5,296,501 $1.51 Million
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.5 $8.73 Million - $14.6 Million	3,233,601 Added 160.49%	5,248,399 $1.43 Million
Q2 2021 Aug 13, 2021	BUY	$4.6 - $7.2 $9.27 Million - $14.5 Million	2,014,798 New	2,014,798 $1.21 Million

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.